FIELD: pharmaceuticals.
SUBSTANCE: present invention relates to new therapeutic tools capable of treating infectious diseases, in particular to a novel pharmaceutical composition, containing an immunoglobulin enriched IgM preparation for use in the adjunctive treatment of severe community-acquired pneumonia (sCAP).
EFFECT: treatment of severe community-acquired pneumonia is suggested.
49 cl, 11 dwg, 5 tbl, 7 ex
Title | Year | Author | Number |
---|---|---|---|
METHODS AND COMPOSITIONS FOR PREVENTION OR TREATMENT OF ACUTE COMPLICATIONS USING POLYCLONAL IMMUNOGLOBULIN | 2019 |
|
RU2806443C2 |
APPLICATION OF ADSORBED DRONE BROOD HOMOGENATE AND GROUP D VITAMINS AND/OR THEIR ACTIVE METABOLITES FOR PREVENTION AND TREATMENT OF ACUTE RESPIRATORY DISEASES AND FLU | 2013 |
|
RU2564111C9 |
ANTIBODY PREPARATIONS | 2011 |
|
RU2749732C2 |
PREPARATIONS OF ANTIBODIES | 2011 |
|
RU2617532C2 |
METHOD FOR DETERMINING ANTI-DRUG ANTIBODY ISOTYPE | 2011 |
|
RU2574976C2 |
IMMUNOGLOBULIN SPRAYING | 2015 |
|
RU2729546C2 |
METHOD FOR PRODUCING IMMUNOGLOBULIN COMPOSITION | 2011 |
|
RU2765738C2 |
METHOD FOR PREPARING COMPOSITION OF IMMUNOGLOBULINS | 2011 |
|
RU2612899C2 |
COMPOSITIONS CONTAINING SECRETOR-LIKE IMMUNOGLOBULINS | 2013 |
|
RU2644240C2 |
METHOD FOR IMMUNOTHERAPY OF PURULENT RHINOSINUSITIS WITH CONCOMITANT TYPE 2 DIABETES MELLITUS | 2020 |
|
RU2763672C1 |
Authors
Dates
2020-11-05—Published
2017-03-13—Filed